PBM 株価分析 — Psyence Biomedical LTD. Common Shares (Healthcare >> Biotechnology)
PBM に関するよくある質問
PBMのPER(株価収益率)は?
Psyence Biomedical LTD. Common Shares(PBM)は現在PER 45.30倍で取引されています。
PBMのROE(自己資本利益率)は?
Psyence Biomedical LTD. Common SharesのROEは-212.63%です。
PBMの配当利回りは?
Psyence Biomedical LTD. Common Sharesの配当利回りは0.00%です。
PBMの品質スコア(Quality Score)は?
当社のAIはPBMの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
PBMは今が買い時ですか?
当社AIのタイミングスコアは100点中51点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
PBMはどのセクターに属しますか?
Psyence Biomedical LTD. Common SharesはHealthcare >> Biotechnologyセクターに分類されます(NASDAQ市場)
PBM AI Analysis Summary
Our AI summary for PBM: Psyence Biomedical LTD. Common Shares (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 45.30, ROE of -212.63%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 51/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 3.29
Price
0.10
(3.13%)
Day Change
|
|
|---|
PBM, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 87 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 3.29 |
| PBV / Sector |
1.08 / 44,105.10
GREAT
|
| Earning Per Share | -6.48 |
| PE / Sector |
45.30 / 19.37
|
| PEG or PE/Growth / Sector |
-0.04 / 1.06
|
| Average 1M Daily Value |
0.25 M
GREAT
|
| Average 1W Daily Value |
0.41 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-06 08:00:28 |
| Symbol | PBM |
| Name | PSYENCE BIOMEDICAL LTD. COMMON SHARES |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 3.81 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 12.82 / 9,702.21 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 121 Richmond Street West, Toronto, ON, Canada, M5H 2K1
Phone: 416-477-1708
Website: https://psyencebiomed.com
Sector: Healthcare >> Biotechnology
Description: Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google